Gallbladder Cancer Foundation Deploys AI to Assist Rare Disease Patients

Gallbladder cancer remains an uncommon and frequently misunderstood diagnosis, leaving many patients to navigate dense pathology reports and disjointed care teams alone. Ari addresses this gap by centralizing medical records into a patient-controlled hub. The tool translates complex biomarker results into plain language, tracks symptoms via voice or text, and assists with administrative hurdles like insurance appeals and clinical trial discovery. By automating these tasks, the platform aims to reduce the logistical burden on families, allowing them to redirect their focus toward treatment and recovery.

Nasha Fitter, co-founder of Citizen Health, developed the technology to serve as a constant companion for those managing high-stakes medical decisions. Sanjeev Kumar, who founded the Gallbladder Cancer Foundation in 2024, emphasized that the initiative is intended to ensure patients have an advocate in their corner throughout their treatment journey. The service is available immediately to the community, with data privacy controls requiring explicit user permission before the AI acts on a patient's behalf. This collaboration marks a significant step in applying proactive, data-driven support to the rare disease landscape, where specialized resources are historically scarce.